CAS: 1085822-09-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | [4,5,6,7-Tetrabromo-2-(Dimethylamino)-1h-Benzimidazol-1-yl]acetic acid REF: 3D-KTB82209CAS: 1085822-09-8 | Min. 95% | A consultar | Mar 21 Ene 25 |
 | CK2/ERK8-IN-1 REF: TM-T10827CAS: 1085822-09-8 | 98.82% | A consultar | Mar 28 Ene 25 |
![[4,5,6,7-Tetrabromo-2-(Dimethylamino)-1h-Benzimidazol-1-yl]acetic acid](https://static.cymitquimica.com/products/3D/thumb/KTB82209.jpg)
[4,5,6,7-Tetrabromo-2-(Dimethylamino)-1h-Benzimidazol-1-yl]acetic acid
CAS:1085822-09-8
Tetrabromo-2-(dimethylamino)-1H-benzimidazole (TBAB) is a novel hdac inhibitor that has been shown to be effective in …
Fórmula:
C11H9Br4N3O2
Pureza:
Min. 95%
Peso molecular:
534.82 g/mol
Ref: 3D-KTB82209
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
CK2/ERK8-IN-1
CAS:1085822-09-8
TMCB inhibits CK2 (Ki: 0.25 µM), ERK8 (IC50: 0.50 µM), PIM1, DYRK1A, HIPK2 (Ki: 8.65-15.25 …
Fórmula:
C11H9Br4N3O2
Pureza:
98.82%
Forma y color:
Solid
Peso molecular:
534.82
Ref: TM-T10827
| 5mg | 35,00 € | ||
| 10mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 28 de Enero de 2025
